Prof. Vanya Maslarska graduated in 1994 from the University of Chemical Technology and Metallurgy-Sofia as a chemical engineer. Since 1995 to the present, she has been successively an assistant, senior and chief assistant, associate professor and professor in the Department of Chemistry. She defended her doctoral dissertation in Pharmaceutical Chemistry in 2010. Prof. Maslarska holds specialities in “Theoretical Basics of Medical Chemistry” and “Drug Analysis” acquired in postgraduate studies at MU-Sofia. She teaches Analytical Chemistry for Masters in Pharmacy and  Analysis of Drugs and Metabolites in Biological Media module from Postgraduate Training in “Clinical Pharmacy”. The scientific interests of Prof. Maslarska are in the fields of Drug Analysis, Bioanalysis, application of instrumental methods – chromatographic, spectral and electrochemical in the characterization of newly synthesized compounds and evaluation of drug substances and forms; analysis of metabolites in biological media; chemometric approaches in analytical chemistry; analytical documentation, standardization files; validation of analytical methods in accordance with the requirements of good laboratory practice. Reviewer for scientific journals – Pharmacia, Reviews in Analytical Chemistry, Analytical Chemistry Letters, Pharmaceutics, European Journal of Chemistry, etc. Member of the Bulgarian Scientific Society of Pharmacy.

Scientific projects:

1. Response to Tafamidis Therapy in hereditary transthyretin amyloidosis due to the pathogenic genetic variant Glu89Gln characteristic of the Bulgarian cohort of patients with a mixed phenotype. Contract No: D-121/24.06.2020, Council of Medical Science, MU – Sofia, Team Leader.
2. Development of a Bioanalytical method for the simultaneous separation of Remdesivir, Dexamethasone and some antidiabetic drugs, as part of the combination therapy of Covid-19 and diabetes. 2022. Council of Medical Science, MU – Sofia. Team Leader
3. Development of a Bioanalytical HPLC procedure for the determination of statins and amiodarone. Determination of the Environmental effect according to the principles of green analytical chemistry. 2024, Contract No. 148/29.05.2024, Council of Medical Science, MU – Sofia, participant.
4. New aryl substituted derivatives of mitonafide and aminonafide with antitumor and sensory activity. 2024, Contract No. 80-10-20/ 08.-04.2024, Scientific Research Fund at Sofia University “St. Kliment Ohridski”, participant.
5. Evaluation and Neuropharmacological Studies of Synthetic Derivatives of N-benzyl pyrrolidine as monoamine oxidase inhibitors. 2024–2026, Contract ZIU-mp-15/09/08/2024, Project BG-RRP-2.004-0004-C01: “Strategic Research and Innovation Program for the Development of MU-Sofia”, in progress, Team Leader.

https://www.scopus.com/authid/detail.uri?authorId=8582982200

https://www.webofscience.com/wos/author/record/3899441

https://ras.nacid.bg/dissertation-preview/37397